Coin-sized, fully integrated, and minimally invasive continuous glucose monitoring system based on organic electrochemical transistors

Jing Bai,Dingyao Liu,Xinyu Tian,Yan Wang,Binbin Cui,Yilin Yang,Shilei Dai,Wensheng Lin,Jixiang Zhu,Jinqiang Wang,Aimin Xu,Zhen Gu,Shiming Zhang

DOI: https://doi.org/10.1126/sciadv.adl1856

IF: 13.6

2024-04-20

Science Advances

Abstract:Continuous glucose monitoring systems (CGMs) are critical toward closed-loop diabetes management. The field's progress urges next-generation CGMs with enhanced antinoise ability, reliability, and wearability. Here, we propose a coin-sized, fully integrated, and wearable CGM, achieved by holistically synergizing state-of-the-art interdisciplinary technologies of biosensors, minimally invasive tools, and hydrogels. The proposed CGM consists of three major parts: (i) an emerging biochemical signal amplifier, the organic electrochemical transistor (OECT), improving the signal-to-noise ratio (SNR) beyond traditional electrochemical sensors; (ii) a microneedle array to facilitate subcutaneous glucose sampling with minimized pain; and (iii) a soft hydrogel to stabilize the skin-device interface. Compared to conventional CGMs, the OECT-CGM offers a high antinoise ability, tunable sensitivity and resolution, and comfort wearability, enabling personalized glucose sensing for future precision diabetes health care. Last, we discuss how OECT technology can help push the limit of detection of current wearable electrochemical biosensors, especially when operating in complicated conditions.

multidisciplinary sciences

What problem does this paper attempt to address?

The paper aims to address several key issues faced by continuous glucose monitoring systems (CGMs) in practical applications:

1. **Improving noise resistance and reliability**: Existing CGMs have deficiencies in resisting noise interference, especially in complex environments, which affects data accuracy.

2. **Enhancing wearing comfort**: Traditional CGMs cause pain to patients when implanting sensors, reducing patient acceptance.

3. **Achieving minimally invasive sampling**: To reduce pain, it is necessary to develop fully integrated and minimally invasive technologies to improve existing solutions.

4. **Improving signal quality**: By using organic electrochemical transistors (OECTs) as biochemical signal amplifiers, the signal-to-noise ratio (SNR) can be significantly improved, surpassing traditional electrochemical sensors.

5. **Achieving personalized glucose monitoring**: For future precise diabetes health management, it is necessary to develop a new generation of CGMs with high noise resistance, adjustable sensitivity and resolution, and comfortable wearing performance.

To address the above issues, the authors propose a coin-sized, fully integrated, and wearable continuous glucose monitoring system (OECT-CGM). This system combines three main components:

1. **Organic Electrochemical Transistor (OECT)**: As an emerging biochemical signal amplifier, it improves the signal-to-noise ratio.

2. **Microneedle Array**: Used for subcutaneous glucose sampling, minimizing pain.

3. **Soft Hydrogel**: Stabilizes the interface between the skin and the device, ensuring device stability during movement.

Compared to traditional CGMs, the OECT-CGM has higher noise resistance, adjustable sensitivity and resolution, and a more comfortable wearing experience, making it highly suitable for future personalized glucose monitoring. Additionally, the paper discusses how to further reduce the detection limit of current wearable electrochemical biosensors using OECT technology, especially when operating under complex conditions.